Yuanli Chemical Group Co.,Ltd.
603217.SS · SHH
Company research
Yuanli Chemical Group Co., Ltd. (603217.SS) is a China-based fine chemicals company founded in 2003 and headquartered in Weifang, Shandong Province, listed on the Shanghai Stock Exchange since June 2019. The company specializes in the research, development, production, and sales of fine chemicals, with core product lines spanning dimethyl esters of dicarboxylic acids, fatty alcohols (including 1,6-hexanediol), and plasticizers (such as DCP and DBP), serving end markets including coatings, polymers, plastic additives, pigments, and pharmaceuticals. As a domestic leader in its niche segment, Yuanli commands over 60% domestic market share in its key products and exports to more than 60 countries and regions worldwide, maintaining long-term supply relationships with over 20 of the world's top 100 multinational chemical groups. The company operates multiple production bases across Weifang and Chongqing, and is actively expanding its industrial chain into bio-based new materials, diol derivatives, and light stabilizers to drive medium- and long-term growth.
Research reports
The article reviews Yuanli’s 2025 results and Q1 2026 performance, highlighting revenue and profit trends across dimethyl dibasic esters, fatty alcohols and plasticizers, as well as improving gross margins supported by an integrated upstream–downstream value chain and diversified product portfolio. It forecasts 2026–2028 net profit growth of over 20% annually, maintains a Buy investment rating, and flags risks from project construction delays, raw‑material and product price volatility, and potential macroeconomic weakness.
华安证券股份有限公司 · December 15, 2025精细化工细分领域领军企业，产业链一体化发展稳步前行This initiating‑coverage report characterizes Yuanli as a leading fine‑chemicals company with globally leading dimethyl dibasic ester capacity and domestically leading fatty alcohol and DCP plasticizer capacity, emphasizing its integrated industrial chain and expansion into bio‑based BDO and polycarbonate diol (PCDL) as key growth drivers. It assigns a Buy rating with detailed 2025–2027 segment revenue, margin and earnings forecasts, while highlighting risks including slower‑than‑expected ramp‑up of new capacity, large swings in raw‑material prices, weaker downstream demand, and export pressure from global economic and trade uncertainties.